Eurofins CDMO vs Lotte Biologics: CDMO Comparison
How does Eurofins CDMO compare to Lotte Biologics for Biologics manufacturing?
Side-by-side comparison of Eurofins CDMO and Lotte Biologics on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Eurofins CDMO has more FDA inspections on record (5 vs 1) — a deeper regulatory paper trail.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
On a 13-modality CDMO landscape, both Eurofins CDMO and Lotte Biologics qualify as Biologics manufacturers; Eurofins CDMO carries the higher composite Signal Score for Biologics programs in this comparison.
What to evaluate for Biologics programs
Both Eurofins CDMO and Lotte Biologics qualify as Biologics CDMOs. When choosing between them for Biologics programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
Scale & bioreactor fit
Match validated bioreactor scale (from a few hundred litres clinical to 2,000L+ commercial) and single-use vs stainless to your dose and indication. Confirm titer expectations for your construct.
Cell line & process development
Ask whether the CDMO offers its own expression platform/cell line or works from yours, and how process development and tech transfer are handled.
Regulatory track record
Biologics programs heading to BLA/MAA need a strong commercial-scale inspection history. Cross-check FDA 483s, warning letters, and EMA/MHRA GMP coverage — all shown above.
Drug substance to drug product
Confirm whether the CDMO covers fill-finish and formulation in-house or coordinates a separate site, which affects timelines and comparability.
Frequently asked: Eurofins CDMO vs Lotte Biologics
How does Eurofins CDMO compare to Lotte Biologics for Biologics manufacturing?
On CDMO Signal's composite Signal Score, Eurofins CDMO is 82/100 and Lotte Biologics is 82/100; Eurofins CDMO has 5 FDA inspections on record vs 1 for Lotte Biologics. Both are tracked in the CDMO Signal directory as Biologics CDMOs. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, Eurofins CDMO or Lotte Biologics?
Both Eurofins CDMO and Lotte Biologics maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Eurofins CDMO has 5 FDA inspections on record; Lotte Biologics has 1.
Which is better for Biologics manufacturing — Eurofins CDMO or Lotte Biologics?
Both Eurofins CDMO and Lotte Biologics are tagged as Biologics CDMOs in our directory, so both are credible options for Biologics programs. The most important differentiator for Biologics selection is typically scale & bioreactor fit: Match validated bioreactor scale (from a few hundred litres clinical to 2,000L+ commercial) and single-use vs stainless to your dose and indication. Confirm titer expectations for your construct. Review each CDMO's profile and inspection record before shortlisting.
What does the Signal Score gap mean in practice?
Eurofins CDMO carries a Signal Score of 82/100 and Lotte Biologics carries 82/100 — essentially tied for Lotte Biologics. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →